Quarterly report · Q3

Period2023-06-01 → 2024-02-29
Filed2024-04-12
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 38
MetricValuePeriodScopeSource row
Revenue¥4.5bn2023-06-01 → 2024-02-29StandaloneNet sales
Revenue¥6.3bn2022-06-01 → 2023-05-31StandaloneNet sales (5-year summary)
Revenue¥4.6bn2022-06-01 → 2023-02-28StandaloneNet sales
Operating income¥252m2023-06-01 → 2024-02-29StandaloneOperating income
Operating income¥325m2022-06-01 → 2023-02-28StandaloneOperating income
Ordinary income¥246m2023-06-01 → 2024-02-29StandaloneOrdinary income
Ordinary income¥351m2022-06-01 → 2023-05-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥309m2022-06-01 → 2023-02-28StandaloneOrdinary income
Profit before tax¥287m2023-06-01 → 2024-02-29StandaloneIncome before income taxes
Profit before tax¥309m2022-06-01 → 2023-02-28StandaloneIncome before income taxes
Net income¥191m2023-06-01 → 2024-02-29StandaloneProfit loss
Net income¥256m2022-06-01 → 2023-05-31StandaloneNet income loss (5-year summary)
Net income¥230m2022-06-01 → 2023-02-28StandaloneProfit loss
Total assets¥5.3bnat 2024-02-29StandaloneAssets
Total assets¥4.9bnat 2023-05-31StandaloneAssets
Total assets¥5.0bnat 2023-02-28StandaloneTotal assets (5-year summary)
Total liabilities¥3.2bnat 2024-02-29StandaloneLiabilities
Total liabilities¥3.0bnat 2023-05-31StandaloneLiabilities
Net assets / equity¥2.1bnat 2024-02-29StandaloneNet assets
Net assets / equity¥1.9bnat 2023-05-31StandaloneNet assets
Net assets / equity¥1.9bnat 2023-02-28StandaloneNet assets (5-year summary)
Cash and deposits¥954mat 2024-02-29StandaloneCash and deposits
Cash and deposits¥853mat 2023-05-31StandaloneCash and deposits
EPS (basic)¥48.22023-06-01 → 2024-02-29StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥24.522023-12-01 → 2024-02-29dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥67.942022-06-01 → 2023-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥61.462022-06-01 → 2023-02-28StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥21.532022-12-01 → 2023-02-28dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥47.272023-06-01 → 2024-02-29StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥64.122022-06-01 → 2023-05-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥58.552022-06-01 → 2023-02-28StandaloneDiluted earnings per share (5-year summary)
Dividend per share¥192022-06-01 → 2023-05-31StandaloneDividend paid per share (5-year summary)
Equity ratio39.9%at 2024-02-29StandaloneEquity to asset ratio (5-year summary)
Equity ratio38.7%at 2023-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio37.5%at 2023-02-28StandaloneEquity to asset ratio (5-year summary)
Shares issued4,095,500at 2024-02-29StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2023-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2023-02-28StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentrevenue2023-06-01 → 2024-02-29¥1.6bn
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentrevenue external2023-06-01 → 2024-02-29¥1.6bn
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentsegment profit2023-06-01 → 2024-02-29−¥22m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentrevenue2023-06-01 → 2024-02-29¥563m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentrevenue external2023-06-01 → 2024-02-29¥563m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentsegment profit2023-06-01 → 2024-02-29−¥40m
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentrevenue2023-06-01 → 2024-02-29¥2.3bn
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2023-06-01 → 2024-02-29¥2.3bn
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2023-06-01 → 2024-02-29¥314m
—segment totalrevenue2023-06-01 → 2024-02-29¥4.5bn
—segment totalrevenue external2023-06-01 → 2024-02-29¥4.5bn
—segment totalsegment profit2023-06-01 → 2024-02-29¥252m
Total Of Reportable Segments And Otherssegment totalrevenue2023-06-01 → 2024-02-29¥4.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-06-01 → 2024-02-29¥4.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-06-01 → 2024-02-29¥252m
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥1.5bn
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥1.5bn
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentsegment profit2022-06-01 → 2023-02-28−¥25m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥528m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥528m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentsegment profit2022-06-01 → 2023-02-28−¥75m
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥2.6bn
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥2.6bn
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2022-06-01 → 2023-02-28¥426m
—segment totalrevenue2022-06-01 → 2023-02-28¥4.6bn
—segment totalrevenue external2022-06-01 → 2023-02-28¥4.6bn
—segment totalsegment profit2022-06-01 → 2023-02-28¥325m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2023-02-28¥4.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2023-02-28¥4.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2023-02-28¥325m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 369
ItemContextValueUnit
Name of shareholder treasury shares etcCurrentQuarterInstant_Row1Member
Original text (Japanese)室町ケミカル株式会社
Address of shareholder treasury shares etcCurrentQuarterInstant_Row1Member
Original text (Japanese)福岡県大牟田市新勝立町一丁目38番5
Information about officers (text)FilingDateInstantText · Plus
Regulations in accordance with which financial statements have been prepared financial informationCurrentYTDDurationText · Plus
Note on independent audit financial informationCurrentYTDDurationText · Plus
Description of fact that consolidated financial statements have not been prepared financial informationCurrentYTDDuration
Original text (Japanese)当社は、子会社がありませんので、四半期連結財務諸表を作成しておりません。
Quarterly balance sheet (text)CurrentYTDDurationText · Plus
Year to quarter end statement of income (text)CurrentYTDDurationText · Plus
Debtors notes regarding overdraft contracts and or loan commitments (text)CurrentQuarterInstant_NonConsolidatedMemberText · Plus
Description of fact that quarterly statement of cash flows has not been prepared (text)CurrentYTDDuration_NonConsolidatedMemberText · Plus
Notes regarding dividend (text)Prior1YTDDuration_NonConsolidatedMemberText · Plus
Notes regarding dividend (text)CurrentYTDDuration_NonConsolidatedMemberText · Plus
Notes segment information etc quarterly financial statements (text)CurrentYTDDurationText · Plus
Footnotes regarding segment information table (text)Prior1YTDDuration_NonConsolidatedMemberText · Plus
Footnotes regarding segment information table (text)CurrentYTDDuration_NonConsolidatedMemberText · Plus
Notes revenue recognition quarterly financial statements (text)CurrentYTDDurationText · Plus
Notes per share information quarterly financial statements (text)CurrentYTDDurationText · Plus
Other information financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2023-05-31pass
balance sheet identitynon_consolidated 2024-02-29pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-05-31pass
statement vs summary · net assetsnon_consolidated 2024-02-29pass
statement vs summary · revenuenon_consolidated 2022-06-01/2023-02-28pass
statement vs summary · revenuenon_consolidated 2023-06-01/2024-02-29pass
statement vs summary · total assetsnon_consolidated 2023-05-31pass
statement vs summary · total assetsnon_consolidated 2024-02-29pass